ad

Sun Pharmaceutical Industries Q2 Results 2025 Highlights: Net Profit Rises by 2.56% & Revenue Up 8.93% YoY

Posted by : sachet | Fri Nov 07 2025

Sun Pharmaceutical Industries Q2 Results 2025 Highlights: Net Profit Rises by 2.56% & Revenue Up 8.93% YoY

Click and Sign Up to Get Live Updates on Q2 Results 

Sun Pharmaceutical Industries Q2 Results FY26: During Q2 FY26, Sun Pharmaceutical Industries’ profit increased 2.56% YoY, while revenue increased by 8.93% YoY. The company posted robust numbers, with Q2 PAT at ₹3,117.95 crores and revenue at ₹14,478.31 crores. Sun Pharmaceutical Industries announced its Q2 results on 5th November 2025.  

Sun Pharmaceutical Industries Q2 Results FY26: Extracts of FY25 & FY26

ParticularsConsolidated FiguresStandalone Figures
30th Sep 202530 Sept 202430th Sept 202530th Sept 2024
Revenue from Operations₹14,478.31₹13,291.39₹4,548.11₹5,122.47
Profit Before Tax (PBT)₹4,996.97₹4,292.96₹1,256.38₹1,427.08
Profit After Tax (PAT)₹3,117.95₹3,040.16₹564.22₹838.37

Sun Pharmaceutical Industries Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

  • Sun Pharmaceutical Industries clocked Q2 FY26 consolidated revenue of ₹14,478.31 crores vs ₹13,291.39 crores. 
  • On the profit front, Sun Pharmaceutical Industries earned a consolidated PAT of ₹3,117.95 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹3,040.16 crore.
  • According to the consolidated figures, Sun Pharmaceutical Industries’ quarterly PAT increased by 2.56% YoY, while revenue increased by 8.93%.
  • Sun Pharmaceutical Industries clocked Q2 FY26 standalone revenue of ₹4,548.11 crores vs ₹5,122.47 crores. 
  • On the profit front, Sun Pharmaceutical Industries earned a standalone PAT of ₹564.22 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹838.37 crore.
  • According to the standalone figures, Sun Pharmaceutical Industries’ quarterly PAT decreased by 32.70% YoY, while revenue decreased by 11.21%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Sun Pharmaceutical Industries Share Price Performance

On the opening bell on 7th November 2025, Sun Pharmaceutical Industries shares opened at ₹1,695.50 per share. However, the initial gains have since eroded, and Sun Pharmaceutical Industries shares are currently trading at ₹1,694.90 per share, which is lower than the opening price.    

Considering the long-term achievements, Sun Pharmaceutical Industries shares have yielded returns of approximately -5.40% over the past years, and 5-year returns stand at 232.91%. Over the maximum timeframe, Sun Pharmaceutical Industries shares delivered a 74,569.60% return to investors. 

What Analysts Expect Post Q2 Results?

Following Sun Pharmaceutical Industries’ robust Q2 results, analysts expect its share price to rise. According to analysts, Sun Pharmaceutical Industries’ share price is expected to reach ₹1,800.00 per share in the coming year; however, in a downturn, it could fall to ₹1,650.20 per share. However, one must ignore stock market volatility and invest in Sun Pharmaceutical Industries’ shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here

Related Posts

Devyani International Q2 Results 2025 Highlights: Net Profit Falls 1,28,847.06% & Revenue Up 12.65% YoY

Abbott India Q2 Results 2025 Highlights: Net Profit Surged by 15.80% & Revenue Up 7.62% YoY

Ola Electric Mobility Q2 Results 2025 Highlights: Net Profit Rises by 15.56% & Revenue Down 43.16% YoY

Workmates Core2Cloud IPO Details: Everything You Should Know about 

Mahamaya Lifesciences IPO Details: Everything You Should Know about 

ad
icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Quick Links: SEBI | NSE | BSE | MCX | Account Opening Process | Policies and Procedures | Register and Track Complaint | SEBI scores | SMART ODR | NSDL e-Voting | USCNBA | Account Closure | ContactUs 
Market Indices: Nifty 50 | Nifty 100 | Sensex | Nifty PSU Bank | Nifty Auto | Nifty 200 | Nifty 500 | Nifty Alpha 50 | Nifty Commodities | Nifty Consumptions | Nifty CPSE | Nifty Div Opps 50 | Nifty Energy | Nifty Growsect 15 | Nifty High Beta 50 | Nifty Fin Services | Nifty Infra | Nifty IT | Nifty Largemid 200 | NIfty Low Volatility 50 | Nifty Mid Cap 100
Screeners: Top Gainers | Top Losers | 52 Week High | 52 Week Low | FIIs Holding Change | DIIs Holding Change | Fundamentally Strong | Upcoming Dividends | Daily Fresh Breakout | Weekly Breakout | Nearing Breakout | Oversold Stocks | Volume Shockers | Golden Crossover | Short Term | Long Term | Top Stocks Result to Watch | Share Market Today
Sharks: Rakesh Jhunjhunwala | Radhakishan Damani | Azim Premji | Mukul Agrawal | Ashish Dhawan | Ashish kacholia | Anil Goel | Bhavook Tripathi | Vijay Kishanlal kedia  | Enam Securities | Vistra ITCL | Punjab National Bank | The Oriental Insurance Company | Jm Financial | GOVT. Of Singapore | EuroPacific Growth Fund | Govt. Pension Fund GLobal
Trending Stocks: ONGC | Zomato | Adani Enterprises | Reliance Industries | IOCL | Bajaj Auto |  Tata Motors | IRFC | IRCTC | Jindal Steel | HUDCO | BHEL | BEL | SBI | Kotak Bank | HDFC | Airtel | Coal India | LIC | Amber Enterprises | Kalyan Jewellers | Titan | JIO Fin Services | TCS | Infosys | Tech Mahindra | HCL | DLF | Godrej | ITC | Hindustan Unilever | NTPC | Power Finance Corp | Deepak Nitrite | Pidilite | Hero Moto Corp | ATUL | Maruti Suzuki | IndusInd Bank | CDSL | Indigo | L&T | RVNL | Grasim | MRF | CEAT | V-Guard
Trending Blogs: EPS Formula | DE Ratio | ROE | PB Ratio | Dividend Yield | PE Ratio | Penny Stocks | Demat Account | Fundamentally Strong Penny Stocks | Fundamentally Strong Stocks In BSE | Debt Free Penny Stocks Below 1 Rupee
General
arrow down